Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease
Clinical trial NCT05098028 · COMPLETED
Trial details
- NCT number
- NCT05098028
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2023-09-04
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.